Table 4 Prognostic factors for overall survival
Factor | N (%) | Univariate analysis | Multivariable analysis | ||
|---|---|---|---|---|---|
P-value | hazard ratio | 95% CIe | P-value | ||
Age: > 70 (vs. ≤ 70) | 19 (44) | 0.535 | |||
Sex: female (vs. male) | 13 (30) | 0.020 | 2.325 | 1.056–5.118 | 0.036 |
ECOG PSa: 1–2 (vs. 0) | 32 (74) | 0.961 | |||
Disease status: recurrence (vs. metastatic) | 9 (21) | 0.446 | |||
Treatment line: 4th or later (vs. 3rd) | 9 (21) | 0.319 | |||
CEAb(ng/mL): > 10.0 (vs. ≤ 10.0) | 23 (53) | 0.344 | |||
CA 19–9c (U/mL): > 2000 (vs. ≤ 2000) | 24 (56) | 0.228 | |||
Albumin (g/dL): ≤ 3.5 (vs. > 3.5) | 24 (56) | 0.082 | 1.158 | 0.452–2.964 | 0.760 |
CRPd (mg/dL): > 1.0 (vs. ≤ 1.0) | 16 (37) | 0.009 | 2.471 | 1.063–5.745 | 0.036 |